Browsing Tag
Neutropenia
5 posts
Physiomics awarded grant for PREDICT-ONC project in precision oncology
Physiomics plc, a leader in mathematical modelling and drug development, announces its latest achievement: securing a grant for…
Lilly announces promising results for Pirtobrutinib Phase 1/2 trials
Eli Lilly’s oncology arm, Loxo@Lilly, disclosed that The New England Journal of Medicine (NEJM) has published an extensive…
Lupin enters Brazilian oncology biosimilars market with Biomm deal for Pegfilgrastim
Lupin partners with Biomm SA to bring biosimilar Pegfilgrastim to Brazil, expanding oncology supportive care access and entering Latin America’s biologics market.
EC approves Pelmeg: Mundipharma’s answer to chemotherapy-induced neutropenia
Mundipharma, a German pharmaceutical company, has achieved a significant milestone with the European Commission (EC)’s approval of Pelmeg,…
Pfizer receives FDA approval for Nivestym, a Neutropenia biosimilar
Pfizer Inc. has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for…